{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T23:47:06Z","timestamp":1788479226429,"version":"build-2803163510"},"reference-count":76,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastrointestinal Endoscopy Clinics of North America"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.giec.2025.02.009","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T03:12:18Z","timestamp":1751425938000},"page":"823-838","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Complicated Celiac Disease"],"prefix":"10.1016","volume":"35","author":[{"given":"Gerd","family":"Bouma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris J.","family":"Mulder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Cellier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.giec.2025.02.009_bib1","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1046\/j.1365-2036.1996.66237000.x","article-title":"Review article: management of patients with non-responsive coeliac disease","volume":"10","author":"O'Mahony","year":"1996","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.giec.2025.02.009_bib2","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1053\/j.gastro.2019.12.016","article-title":"Most patients with celiac disease on gluten-free diets consume measurable amounts of gluten","volume":"158","author":"Silvester","year":"2020","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1016\/j.giec.2025.02.009_bib3","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.3748\/wjg.v18.i12.1348","article-title":"Celiac disease: management of persistent symptoms in patients on a gluten-free diet","volume":"18","author":"Dewar","year":"2012","journal-title":"World J Gastroenterol"},{"issue":"5","key":"10.1016\/j.giec.2025.02.009_bib4","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/apt.12621","article-title":"Predictors of persistent villous atrophy in coeliac disease: a population-based study","volume":"39","author":"Lebwohl","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.giec.2025.02.009_bib5","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1053\/j.gastro.2024.01.029","article-title":"Diagnosis of seronegative and ultrashort celiac disease","volume":"167","author":"Volta","year":"2024","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1016\/j.giec.2025.02.009_bib6","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1136\/gut.2005.071514","article-title":"Endomysial antibody-negative coeliac disease: clinical characteristics and intestinal autoantibody deposits","volume":"55","author":"Salmi","year":"2006","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.giec.2025.02.009_bib7","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1053\/j.gastro.2017.11.006","article-title":"HLA-DQ-Gluten tetramer blood test accurately identifies patients with and without celiac disease in absence of gluten consumption","volume":"154","author":"Sarna","year":"2018","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.giec.2025.02.009_bib8","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/cei.13578","article-title":"Whole blood interleukin-2 release test to detect and characterize rare circulating gluten-specific T cell responses in coeliac disease","volume":"204","author":"Anderson","year":"2021","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.giec.2025.02.009_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2021.102609","article-title":"Immune-mediated enteropathies: from bench to bedside","volume":"118","author":"van Wanrooij","year":"2021","journal-title":"J Autoimmun"},{"issue":"1","key":"10.1016\/j.giec.2025.02.009_bib10","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgast-2021-000630","article-title":"Enteropathies with villous atrophy but negative coeliac serology in adults: current issues","volume":"8","author":"Schiepatti","year":"2021","journal-title":"BMJ Open Gastroenterol"},{"issue":"8","key":"10.1016\/j.giec.2025.02.009_bib11","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.mayocp.2012.06.003","article-title":"Severe spruelike enteropathy associated with olmesartan","volume":"87","author":"Rubio-Tapia","year":"2012","journal-title":"Mayo Clin Proc"},{"issue":"11","key":"10.1016\/j.giec.2025.02.009_bib12","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1038\/ajg.2017.281","article-title":"A pitfall in suspected (refractory) celiac disease: losartan-induced enteropathy","volume":"112","author":"van Gils","year":"2017","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"10.1016\/j.giec.2025.02.009_bib13","doi-asserted-by":"crossref","first-page":"471","DOI":"10.6002\/ect.2023.0034","article-title":"Celiac-like duodenopathy associated with enteric-coated mycophenolate sodium immunosuppression in renal transplant recipients: report of 4 cases","volume":"21","author":"Ivanovski","year":"2023","journal-title":"Exp Clin Transplant"},{"issue":"11\u201312","key":"10.1016\/j.giec.2025.02.009_bib14","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1111\/apt.16642","article-title":"Review article: drug-induced small bowel injury","volume":"54","author":"Hamdeh","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.giec.2025.02.009_bib15","doi-asserted-by":"crossref","DOI":"10.7573\/dic.2022-6-3","article-title":"Small bowel villous atrophy due to immune-checkpoint inhibitors: report of two cases and literature review","volume":"11","author":"Schiepatti","year":"2022","journal-title":"Drugs Context"},{"issue":"2","key":"10.1016\/j.giec.2025.02.009_bib16","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s10875-022-01379-2","article-title":"Interferon-driven immune dysregulation in common variable immunodeficiency-associated villous atrophy and norovirus infection","volume":"43","author":"Strohmeier","year":"2023","journal-title":"J Clin Immunol"},{"issue":"11","key":"10.1016\/j.giec.2025.02.009_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0078664","article-title":"Autoantibodies to harmonin and villin are diagnostic markers in children with IPEX syndrome","volume":"8","author":"Lampasona","year":"2013","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.giec.2025.02.009_bib18","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000387","article-title":"Adult-onset autoimmune enteropathy in an European tertiary referral center","volume":"12","author":"van Wanrooij","year":"2021","journal-title":"Clin Transl Gastroenterol"},{"issue":"11","key":"10.1016\/j.giec.2025.02.009_bib75","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.cgh.2007.05.013","article-title":"Adult autoimmune enteropathy: Mayo Clinic Rochester experience","volume":"5","author":"Akram","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.giec.2025.02.009_bib19","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1016\/j.cgh.2022.07.030","article-title":"Genetic diagnosis guides treatment of autoimmune enteropathy","volume":"21","author":"Charbit-Henrion","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"14","key":"10.1016\/j.giec.2025.02.009_bib20","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.3390\/nu16142233","article-title":"Microscopic colitis and celiac disease: sharing more than a diagnostic overlap","volume":"16","author":"Gonz\u00e1lez-Castro","year":"2024","journal-title":"Nutrients"},{"issue":"8","key":"10.1016\/j.giec.2025.02.009_bib21","doi-asserted-by":"crossref","first-page":"3421","DOI":"10.1007\/s10620-023-07965-7","article-title":"Exocrine pancreatic insufficiency is common in celiac disease: a systematic review and meta-analysis","volume":"68","author":"Jiang","year":"2023","journal-title":"Dig Dis Sci"},{"issue":"7","key":"10.1016\/j.giec.2025.02.009_bib22","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/j.cgh.2024.01.048","article-title":"Association between celiac disease and irritable bowel syndrome: a nationwide cohort study","volume":"22","author":"M\u00e5rild","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.giec.2025.02.009_bib23","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.cgh.2012.11.033","article-title":"Prevalence of irritable bowel syndrome-type symptoms in patients with celiac disease: a meta-analysis","volume":"11","author":"Sainsbury","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"Suppl 1","key":"10.1016\/j.giec.2025.02.009_bib24","first-page":"S49","article-title":"Review article: follow-up of coeliac disease","volume":"56 Suppl 1","author":"Tye-Din","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"issue":"11","key":"10.1016\/j.giec.2025.02.009_bib25","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1136\/gutjnl-2023-329751","article-title":"Persistent villous atrophy predicts development of complications and mortality in adult patients with coeliac disease: a multicentre longitudinal cohort study and development of a score to identify high-risk patients","volume":"72","author":"Schiepatti","year":"2023","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.giec.2025.02.009_bib26","doi-asserted-by":"crossref","DOI":"10.1038\/ctg.2016.70","article-title":"Outcome of referrals for non-responsive celiac disease in a tertiary center: low incidence of refractory celiac disease in The Netherlands","volume":"8","author":"van Wanrooij","year":"2017","journal-title":"Clin Transl Gastroenterol"},{"issue":"5","key":"10.1016\/j.giec.2025.02.009_bib27","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1038\/ajg.2011.104","article-title":"The incidence and clinical spectrum of refractory celiac disease in a north American referral center","volume":"106","author":"Roshan","year":"2011","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.giec.2025.02.009_bib28","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.dld.2013.10.010","article-title":"Low incidence but poor prognosis of complicated coeliac disease: a retrospective multicentre study","volume":"46","author":"Biagi","year":"2014","journal-title":"Dig Liver Dis"},{"issue":"3","key":"10.1016\/j.giec.2025.02.009_bib29","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.dld.2021.06.026","article-title":"Antitissue transglutaminase antibodies\u2019 normalization after starting a gluten-free diet in a large population of celiac children-a real-life experience","volume":"54","author":"Sbravati","year":"2022","journal-title":"Dig Liver Dis"},{"issue":"9","key":"10.1016\/j.giec.2025.02.009_bib30","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1111\/apt.16075","article-title":"Exposure sources, amounts and time course of gluten ingestion and excretion in patients with coeliac disease on a gluten-free diet","volume":"52","author":"Silvester","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.giec.2025.02.009_bib31","first-page":"132","article-title":"Advances in nonresponsive and refractory celiac disease","volume":"167","author":"Malamut","year":"2024","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.giec.2025.02.009_bib32","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1136\/gut.2009.195131","article-title":"Classification and management of refractory coeliac disease","volume":"59","author":"Rubio-Tapia","year":"2010","journal-title":"Gut"},{"issue":"10","key":"10.1016\/j.giec.2025.02.009_bib33","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1136\/gut.2006.114512","article-title":"Survival in refractory coeliac disease and enteropathy-associated T-cell lymphoma: retrospective evaluation of single-centre experience","volume":"56","author":"Al-Toma","year":"2007","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.giec.2025.02.009_bib34","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1053\/j.gastro.2008.09.069","article-title":"Presentation and long-term follow-up of refractory celiac disease: comparison of type I with type II","volume":"136","author":"Malamut","year":"2009","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.giec.2025.02.009_bib35","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/MCG.0b013e3181f42401","article-title":"Small intestinal release mesalamine for the treatment of refractory celiac disease type I","volume":"45","author":"Jamma","year":"2011","journal-title":"J Clin Gastroenterol"},{"issue":"1","key":"10.1016\/j.giec.2025.02.009_bib36","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1159\/000092639","article-title":"Therapy with budesonide in patients with refractory sprue","volume":"73","author":"Daum","year":"2006","journal-title":"Digestion"},{"issue":"10","key":"10.1016\/j.giec.2025.02.009_bib37","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1111\/j.1572-0241.2007.01380.x","article-title":"Budesonide in the treatment of refractory celiac disease","volume":"102","author":"Brar","year":"2007","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"10.1016\/j.giec.2025.02.009_bib38","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/ajg.2017.71","article-title":"Open-capsule budesonide for refractory celiac disease","volume":"112","author":"Mukewar","year":"2017","journal-title":"Am J Gastroenterol"},{"issue":"7","key":"10.1016\/j.giec.2025.02.009_bib39","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1007\/s10620-024-08436-3","article-title":"Budesonide induces favourable histologic and symptomatic recovery in patients with non-responsive and refractory coeliac disease when given in an open capsule format","volume":"69","author":"Saitta","year":"2024","journal-title":"Dig Dis Sci"},{"issue":"5","key":"10.1016\/j.giec.2025.02.009_bib40","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1046\/j.1365-2036.2003.01687.x","article-title":"Azathioprine and prednisone combination therapy in refractory coeliac disease","volume":"18","author":"Goerres","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.giec.2025.02.009_bib41","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1365-2036.2012.05154.x","article-title":"Tioguanine in the treatment of refractory coeliac disease--a single centre experience","volume":"36","author":"Tack","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.giec.2025.02.009_bib42","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1053\/gast.2002.31874","article-title":"Successful infliximab treatment for steroid-refractory celiac disease: a case report","volume":"122","author":"Gillett","year":"2002","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.giec.2025.02.009_bib43","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1097\/00042737-200506000-00012","article-title":"Refractory coeliac disease: remission with infliximab and immunomodulators","volume":"17","author":"Turner","year":"2005","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.giec.2025.02.009_bib44","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1177\/2050640616663571","article-title":"Splenic volume differentiates complicated and non-complicated celiac disease","volume":"5","author":"van Gils","year":"2017","journal-title":"United European Gastroenterol J"},{"issue":"2","key":"10.1016\/j.giec.2025.02.009_bib45","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s11739-019-02129-w","article-title":"Defective spleen function in autoimmune gastrointestinal disorders","volume":"15","author":"Giuffrida","year":"2020","journal-title":"Intern Emerg Med"},{"issue":"1","key":"10.1016\/j.giec.2025.02.009_bib46","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1148\/radiol.11101808","article-title":"MR enteroclysis in refractory celiac disease: proposal and validation of a severity scoring system","volume":"259","author":"Van Weyenberg","year":"2011","journal-title":"Radiology"},{"issue":"10","key":"10.1016\/j.giec.2025.02.009_bib47","first-page":"1622","article-title":"18F-FDG PET versus CT for the detection of enteropathy-associated T-cell lymphoma in refractory celiac disease","volume":"47","author":"Hadithi","year":"2006","journal-title":"J Nucl Med"},{"issue":"10","key":"10.1016\/j.giec.2025.02.009_bib48","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.1182\/blood.V92.10.3879","article-title":"Are complicated forms of celiac disease cryptic T-cell lymphomas?","volume":"92","author":"Carbonnel","year":"1998","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.giec.2025.02.009_bib49","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0016-5085(98)70530-X","article-title":"Abnormal intestinal intraepithelial lymphocytes in refractory sprue","volume":"114","author":"Cellier","year":"1998","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.giec.2025.02.009_bib50","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1182\/blood.V94.1.260.413k40_260_264","article-title":"Mucosal intra-epithelial lymphocytes in enteropathy-associated T-cell lymphoma, ulcerative jejunitis, and refractory celiac disease constitute a neoplastic population","volume":"94","author":"Bagdi","year":"1999","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.giec.2025.02.009_bib51","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.immuni.2016.07.018","article-title":"Interleukin-15-dependent T-cell-like innate intraepithelial lymphocytes develop in the intestine and transform into lymphomas in celiac disease","volume":"45","author":"Ettersperger","year":"2016","journal-title":"Immunity"},{"issue":"5","key":"10.1016\/j.giec.2025.02.009_bib52","doi-asserted-by":"crossref","first-page":"e208","DOI":"10.1097\/MCG.0000000000001060","article-title":"Gamma-delta T lymphocytes in the diagnostic approach of coeliac disease","volume":"53","author":"Nijeboer","year":"2019","journal-title":"J Clin Gastroenterol"},{"issue":"7","key":"10.1016\/j.giec.2025.02.009_bib53","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1007\/s10875-014-0075-7","article-title":"Optimal strategies to identify aberrant intra-epithelial lymphocytes in refractory coeliac disease","volume":"34","author":"van Wanrooij","year":"2014","journal-title":"J Clin Immunol"},{"issue":"12","key":"10.1016\/j.giec.2025.02.009_bib54","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1136\/gut.2010.223438","article-title":"Accurate classification of RCD requires flow cytometry","volume":"59","author":"van Wanrooij","year":"2010","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.giec.2025.02.009_bib55","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.molimm.2012.01.014","article-title":"Origin and immunophenotype of aberrant IEL in RCDII patients","volume":"50","author":"Tack","year":"2012","journal-title":"Mol Immunol"},{"issue":"1","key":"10.1016\/j.giec.2025.02.009_bib56","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jmoldx.2018.08.006","article-title":"A single-tube, EuroClonality-inspired, TRG clonality multiplex PCR aids management of patients with enteropathic diseases, including from formaldehyde-fixed, paraffin-embedded tissues","volume":"21","author":"Derrieux","year":"2019","journal-title":"J Mol Diagn"},{"issue":"8","key":"10.1016\/j.giec.2025.02.009_bib57","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1136\/gutjnl-2018-317371","article-title":"NKp46 is a diagnostic biomarker and may be a therapeutic target in gastrointestinal T-cell lymphoproliferative diseases: a CELAC study","volume":"68","author":"Cheminant","year":"2019","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.giec.2025.02.009_bib58","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jcmgh.2022.03.005","article-title":"Single-cell analysis of refractory celiac disease demonstrates inter- and intra-patient aberrant cell heterogeneity","volume":"14","author":"Dieckman","year":"2022","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.giec.2025.02.009_bib59","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1136\/gutjnl-2020-322935","article-title":"Oncogenetic landscape of lymphomagenesis in coeliac disease","volume":"71","author":"Cording","year":"2022","journal-title":"Gut"},{"issue":"7","key":"10.1016\/j.giec.2025.02.009_bib60","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1097\/PAS.0000000000001658","article-title":"Immunophenotypic spectrum and genomic landscape of refractory celiac disease type II","volume":"45","author":"Soderquist","year":"2021","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.giec.2025.02.009_bib61","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.immuni.2004.06.018","article-title":"A direct role for NKG2D\/MICA interaction in villous atrophy during celiac disease","volume":"21","author":"H\u00fce","year":"2004","journal-title":"Immunity"},{"issue":"11","key":"10.1016\/j.giec.2025.02.009_bib62","doi-asserted-by":"crossref","first-page":"6304","DOI":"10.4049\/jimmunol.1003382","article-title":"DNAM-1 mediates epithelial cell-specific cytotoxicity of aberrant intraepithelial lymphocyte lines from refractory celiac disease type II patients","volume":"186","author":"Tjon","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.giec.2025.02.009_bib76","series-title":"Refractory Celiac Disease","first-page":"123","article-title":"Treatment of Refractory Celiac Disease","author":"Bouma","year":"2022"},{"issue":"1","key":"10.1016\/j.giec.2025.02.009_bib63","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1053\/j.gastro.2008.10.013","article-title":"Clinical staging and survival in refractory celiac disease: a single center experience","volume":"136","author":"Rubio-Tapia","year":"2009","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1016\/j.giec.2025.02.009_bib64","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1016\/S0002-9270(02)04387-3","article-title":"Azathioprine in refractory sprue: results from a prospective, open-label study","volume":"97","author":"Mauri\u00f1o","year":"2002","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"10.1016\/j.giec.2025.02.009_bib65","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1046\/j.1365-2036.2000.00718.x","article-title":"Cyclosporin in the treatment of adults with refractory coeliac disease--an open pilot study","volume":"14","author":"Wahab","year":"2000","journal-title":"Aliment Pharmacol Ther"},{"issue":"23","key":"10.1016\/j.giec.2025.02.009_bib66","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1056\/NEJMc053129","article-title":"Alemtuzumab for refractory celiac disease in a patient at risk for enteropathy-associated T-cell lymphoma","volume":"354","author":"Vivas","year":"2006","journal-title":"N Engl J Med"},{"issue":"13","key":"10.1016\/j.giec.2025.02.009_bib67","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1056\/NEJMc061784","article-title":"Alemtuzumab for refractory celiac disease","volume":"355","author":"Verbeek","year":"2006","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.giec.2025.02.009_bib68","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1016\/j.cgh.2006.07.007","article-title":"Cladribine therapy in refractory celiac disease with aberrant T cells","volume":"4","author":"Al-Toma","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.giec.2025.02.009_bib69","doi-asserted-by":"crossref","first-page":"506","DOI":"10.3748\/wjg.v17.i4.506","article-title":"Evaluation of Cladribine treatment in refractory celiac disease type II","volume":"17","author":"Tack","year":"2011","journal-title":"World J Gastroenterol"},{"issue":"6","key":"10.1016\/j.giec.2025.02.009_bib70","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/bmt.2010.199","article-title":"Auto-SCT in refractory celiac disease type II patients unresponsive to cladribine therapy","volume":"46","author":"Tack","year":"2011","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1016\/j.giec.2025.02.009_bib71","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1177\/2050640616646529","article-title":"Lymphoma development and survival in refractory coeliac disease type II: histological response as prognostic factor","volume":"5","author":"Nijeboer","year":"2017","journal-title":"United European Gastroenterol J"},{"issue":"12","key":"10.1016\/j.giec.2025.02.009_bib72","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/S2468-1253(19)30265-1","article-title":"Safety and efficacy of AMG 714 in patients with type 2 refractory coeliac disease: a phase 2a, randomised, double-blind, placebo-controlled, parallel-group study","volume":"4","author":"Cellier","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.giec.2025.02.009_bib73","doi-asserted-by":"crossref","first-page":"E980.e9","DOI":"10.1073\/pnas.1620036114","article-title":"CD4 T-cell cytokines synergize to induce proliferation of malignant and nonmalignant innate intraepithelial lymphocytes","volume":"114","author":"Kooy-Winkelaar","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"10.1016\/j.giec.2025.02.009_bib74","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1016\/j.cgh.2024.05.022","article-title":"Enduring clinical remission in refractory celiac disease type II with tofacitinib: an open-label clinical study","volume":"22","author":"Dieckman","year":"2024","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["Gastrointestinal Endoscopy Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1052515725000297?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1052515725000297?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T23:01:18Z","timestamp":1761433278000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1052515725000297"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":76,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S1052515725000297"],"URL":"https:\/\/doi.org\/10.1016\/j.giec.2025.02.009","relation":{},"ISSN":["1052-5157"],"issn-type":[{"value":"1052-5157","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Complicated Celiac Disease","name":"articletitle","label":"Article Title"},{"value":"Gastrointestinal Endoscopy Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.giec.2025.02.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}